COVID-19 vaccines
Indian Foreign Secretary Harsh V Shringla has revealed that the country is engaging in discussions with major pharmaceutical companies, including Pfizer, Johnson & Johnson, and Moderna, to secure and possibly manufacture COVID-19 vaccines locally. This initiative comes as India aims to boost vaccine production for both domestic consumption and export.
COVID-19 vaccines
A recent report from AstraZeneca has raised concerns about the mortality rate associated with the Pfizer coronavirus vaccine in six European countries. According to the 12-page report, titled "Restoring Confidence in COVID-19 Vaccines and Improved Co-operation Between Regulatory, Healthcare Agencies and Pharmaceutical Companies -- A Call for Action,"
COVID-19 vaccines
A recent survey conducted by Social Weather Stations (SWS) has shown that six out of ten Filipinos prefer vaccines made in the United States, with 63% of respondents expressing a desire to receive US-made vaccine shots. The survey, which involved 1,200 respondents, also highlighted the top five preferred countries
COVID-19 vaccines
The United States has pre-ordered hundreds of millions of COVID-19 vaccine doses, with the government paying billions to pharmaceutical companies like Pfizer and Moderna. This approach has eliminated barriers to access for millions of people, including those who are uninsured or undocumented. However, once the federal health emergency ends, the
Vaccines
BioNTech SE, the vaccine maker, is designating Singapore as its regional headquarters for South-east Asia and plans to set up a messenger RNA (mRNA) manufacturing facility. The facility will produce Covid-19 vaccines and create at least 80 jobs, including roles in quality control, quality assurance, and management. The expansion plan
Vaccines
Pfizer Inc and BioNTech SE have announced a rolling submission of a Biologics License Application (BLA) to the US Food and Drug Administration (FDA) for their mRNA vaccine to prevent COVID-19 in individuals 16 years of age and older, with a request for priority review. The vaccine is currently available
COVID-19 vaccines
As the global COVID-19 vaccine shortage persists, US President Joe Biden has joined the call of 100 nations to waive vaccine producer patents to speed up vaccination efforts. However, the problem is more complex than presented, with multiple patents involved in vaccine production and a lack of sufficient production facilities.
COVID-19 vaccines
The US Food and Drug Administration is set to approve Pfizer/BioNTech's Covid-19 vaccine for children ages 12 to 15 next week, based on a report stating that the FDA is reviewing scientific data provided by Pfizer. This comes as another American pharma firm, Moderna, is also testing
COVID-19 vaccines
The head of India's Serum Institute, the world's biggest vaccine manufacturer, has warned that the country's severe vaccine shortage will continue until July, when production is expected to rise from about 60m-70m doses a month to 100m. The shortage has been exacerbated by the
COVID-19 vaccines
The TempAid 48-hour vaccine packaging solution, developed by Rapid Aid and Woodbridge, has been qualified to provide optimal temperature stability for COVID-19 vaccine shipments across Canada. The solution addresses the challenges related to vaccine storage and distribution, ensuring that vaccines remain effective and provide consistent protection. The packaging system has
COVID-19 vaccines
The European Union's executive arm has taken legal action against AstraZeneca, accusing the pharmaceutical company of failing to meet the terms of its contract for the delivery of COVID-19 vaccines. The dispute arose from AstraZeneca's delayed delivery of doses, which hindered Europe's vaccination campaign
AstraZeneca PLC
The standoff between the European Union and the United Kingdom over COVID-19 vaccine access escalated, with France accusing the UK of "blackmail" and Russia and China of misusing vaccines to boost their foreign policy influence. French Foreign Minister Jean-Yves Le Drian criticized the UK's handling of
